Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients.
Sobuś A, Baumert B, Gołąb-Janowska M, Kulig P, Paczkowska E, Łuczkowska K, Rogińska D, Zawiślak A, Milczarek S, Osękowska B, Pawlukowska W, Meller A, Machowska-Sempruch K, Wełnicka A, Nowacki P, Machaliński B.
Sobuś A, et al. Among authors: zawislak a.
J Clin Med. 2021 Nov 11;10(22):5251. doi: 10.3390/jcm10225251.
J Clin Med. 2021.
PMID: 34830531
Free PMC article.